A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy Participants
Clinical trial NCT05996874 · COMPLETED
Trial details
- NCT number
- NCT05996874
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-12
- Primary completion
- 2024-04-18
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.